MetLife Investment Management’s Cerence CRNC Stock Holding History

MetLife Investment Management’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$287K	Buy	25,329 +2,914	+13%	+$28.5K	﹤0.01%	2230
2026 Q1	$141K	Sell	22,415 -776	-3%	-$6.99K	﹤0.01%	2381
2025 Q4	$248K	Buy	23,191 +2,532	+12%	+$27.8K	﹤0.01%	2171
2025 Q3	$257K	Sell	20,659 -4,146	-17%	-$42.5K	﹤0.01%	2175
2025 Q2	$253K	Hold	24,805	–	–	﹤0.01%	2061
2025 Q1	$196K	Sell	24,805 -511	-2%	-$6.29K	﹤0.01%	2219
2024 Q4	$199K	Buy	+25,316	New	+$127K	﹤0.01%	2306
2024 Q2	–	Sell	-20,536	Closed	-$323K	–	2890
2024 Q1	$323K	Hold	20,536	–	–	﹤0.01%	1922
2023 Q4	$404K	Hold	20,536	–	–	﹤0.01%	1816
2023 Q3	$418K	Hold	20,536	–	–	﹤0.01%	1741
2023 Q2	$600K	Hold	20,536	–	–	﹤0.01%	1573
2023 Q1	$577K	Hold	20,536	–	–	﹤0.01%	1557
2022 Q4	$381K	Hold	20,536	–	–	﹤0.01%	1821
2022 Q3	$323K	Hold	20,536	–	–	﹤0.01%	1951
2022 Q2	$518K	Hold	20,536	–	–	﹤0.01%	1637
2022 Q1	$741K	Sell	20,536 -10,950	-35%	-$539K	﹤0.01%	1524
2021 Q4	$2.41M	Buy	31,486 +160	+0.5%	+$14.1K	0.02%	798
2021 Q3	$3.01M	Buy	31,326 +17,477	+126%	+$1.91M	0.03%	633
2021 Q2	$1.48M	Hold	13,849	–	–	0.01%	990
2021 Q1	$1.24M	Sell	13,849 -1,055	-7%	-$116K	0.01%	1049
2020 Q4	$1.5M	Sell	14,904 -1,404	-9%	-$105K	0.01%	952
2020 Q3	$797K	Hold	16,308	–	–	0.01%	1142
2020 Q2	$666K	Buy	+16,308	New	+$468K	0.01%	1224

Other funds holding CRNC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

OFCM

One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

MetLife Investment Management's CRNC Position: Q2 2026 in Review

MetLife Investment Management increased its Cerence (CRNC) stake by 13% in Q2 2026, buying an estimated $28.5K and bringing the position to 25,329 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

MetLife Investment Management first reported a position in CRNC in Q2 2020 and has held it in 23 quarters since. The position peaked at $3.01M in Q3 2021. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

MetLife Investment Management held 25,329 shares of Cerence worth $287K as of Q2 2026.
MetLife Investment Management bought 2,914 Cerence shares in Q2 2026, an estimated $28.5K.
Cerence made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2230 holding.
MetLife Investment Management first reported a position in Cerence in Q2 2020 and has held it in 23 quarters since.
MetLife Investment Management's Cerence position peaked at $3.01M in Q3 2021.
194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.